Inj. Cepons - Cefoperazone + Sulbactam

---

Mechanism of Action

• Cefoperazone binds to penicillin-binding proteins (PBPs) and inhibits bacterial cell wall synthesis.
• Sulbactam is a beta-lactamase inhibitor - it irreversibly binds and blocks the beta-lactamases that bacteria produce to destroy cefoperazone, thus restoring its activity against resistant organisms.
• Sulbactam also has intrinsic activity against Acinetobacter spp., making this combination particularly valuable for MDR Acinetobacter infections. - Goodman & Gilman's, p. 608

---

Spectrum of Activity

Note: Not active against MRSA, Listeria, or Enterococcus (consider adding vancomycin or ampicillin for those).

---

Indications

• Severe respiratory tract infections (HAP, VAP)
• Complicated UTIs and pyelonephritis
• Intra-abdominal infections and peritonitis
• Septicemia / bacteremia
• Skin and soft tissue infections
• Nosocomial infections with suspected resistant gram-negatives (especially Klebsiella, Acinetobacter, Pseudomonas)
• Febrile neutropenia

---

Dosage & Administration

---

Dose Adjustments

• Renal impairment:
  • CrCl 15-30 mL/min: Max sulbactam 1 g every 12 hrs
  • CrCl <15 mL/min: Max sulbactam 500 mg every 12 hrs
  • No dose adjustment needed for cefoperazone in renal failure
• Hepatic impairment / biliary obstruction: Max cefoperazone 4 g/day (cefoperazone is primarily biliary-excreted)
• Hemodialysis: Dose after dialysis session

---

Adverse Effects

• GI: Diarrhea, nausea, abdominal pain (most common)
• Hematologic: Eosinophilia, prolonged PT/INR (cefoperazone inhibits Vitamin K-dependent clotting factors), hemolytic anemia, leukopenia
• Hepatic: Transient elevation of liver enzymes
• Skin: Rashes, urticaria
• Disulfiram-like reaction: Cefoperazone has an N-methylthiotetrazole (NMTT) side chain - alcohol must be avoided during and for several days after treatment

---

Contraindications & Precautions

• Hypersensitivity to cephalosporins or penicillins (cross-reactivity ~1-2%)
• Use with caution in patients on anticoagulants (monitor INR - consider Vitamin K supplementation)
• When combined with aminoglycosides (e.g., amikacin, gentamicin): monitor renal function closely
• Use in pregnancy/lactation only if clearly necessary

---

Key Clinical Pearl

---

💊 Commonly Used IPD Drugs

---

1. IV FLUIDS (Most Used in IPD)

---

2. ANTIBIOTICS (Injectable)

---

3. ANALGESICS & ANTI-INFLAMMATORY

---

4. PROTON PUMP INHIBITORS / GI DRUGS

---

5. STEROIDS

---

6. CARDIAC DRUGS

---

7. RESPIRATORY DRUGS

---

8. NEUROLOGICAL / SEDATION

---

9. ANTIDIABETIC / METABOLIC

---

10. ANTICOAGULANTS & HAEMATOLOGY

---

11. COMMONLY USED VITAMINS & SUPPLEMENTS (IPD)

---

12. EMERGENCY / RESUSCITATION DRUGS

---

Quick Reference: Most Frequently Written IPD Prescriptions

1. IV Fluids (RL/NS) - almost every patient
2. Inj. Ceftriaxone or Cefoperazone-Sulbactam - infections
3. Inj. Pantoprazole - GI protection
4. Inj. Ondansetron - nausea/vomiting
5. Inj. Paracetamol - fever/pain
6. Inj. Furosemide - fluid overload
7. Inj. Insulin - glucose control
8. Inj. Enoxaparin - DVT prophylaxis
9. Inj. Metronidazole - anaerobic cover
10. Inj. Dexamethasone - anti-inflammatory

---

Note: Drug selection in IPD is guided by the clinical diagnosis, culture sensitivity results, hospital antibiotic policy, patient weight, renal/hepatic function, and local formulary/essential medicines list. Always verify doses before prescribing.

---

When to Give Which Antibiotic

The 4 Key Principles of Antibiotic Selection

1. Site of infection - which organisms typically infect that site?
2. Gram stain / culture result - narrow based on sensitivity
3. Severity - mild → narrow spectrum; severe/ICU → broad spectrum
4. Patient factors - allergies, renal/hepatic function, pregnancy, immunocompromised

---

Part 1: By Antibiotic Class - What Each Is For

🔵 PENICILLINS

---

🔵 CEPHALOSPORINS (by Generation)

Rule of thumb: Higher generation = more Gram-negative coverage, less Gram-positive. 5th generation adds MRSA. - Harrison's, p. 1202-1215

---

🔵 CARBAPENEMS - "Last Resort Broad-Spectrum"

When to escalate to carbapenems: ESBL-producing organisms, KPC on culture; failure of 3rd-gen cephalosporins; severe sepsis with unknown organism.

---

🔵 AMINOGLYCOSIDES

Never use alone for serious infections - always as combination therapy. Monitor renal function and trough levels. Avoid in renal failure if possible.

---

🔵 FLUOROQUINOLONES

Avoid in pregnancy, children <18 years, tendon injury risk. Reserve for cases where beta-lactams have failed or not suitable.

---

🔵 MACROLIDES

---

🔵 TETRACYCLINES

---

🔵 GLYCOPEPTIDES - Anti-MRSA/Resistant Gram-positive

Trigger for glycopeptides: suspected/confirmed MRSA, nosocomial infection with unknown Gram-positive organism, IV line infections, post-surgical wound infections.

---

🔵 METRONIDAZOLE / NITROIMIDAZOLES

---

🔵 ANTI-PSEUDOMONAL DRUGS (Escalation Ladder)

Mild-Moderate: Ciprofloxacin or Ceftazidime
Moderate-Severe: Piperacillin-Tazobactam or Cefepime
Severe / ICU: Meropenem ± Amikacin
MDR Pseudomonas: Ceftazidime-Avibactam or Ceftolozane-Tazobactam

---

Part 2: By Infection Site - Empirical Antibiotic Choice

🫁 RESPIRATORY

---

🚽 URINARY TRACT

---

🩺 INTRA-ABDOMINAL

---

🧠 CNS (Meningitis)

---

❤️ INFECTIVE ENDOCARDITIS

---

🩸 SEPSIS / BACTEREMIA (Empirical)

---

Part 3: By Organism - Drug of Choice

• Jawetz Microbiology, Table 28-3; Harrison's Principles, p. 1202-1215

---

Part 4: Escalation Ladder (Severity-Based)

MILD (OPD)
   ↓
Amoxicillin / Cephalexin / Azithromycin / Doxycycline

MODERATE (IPD - ward)
   ↓
Ceftriaxone / Cefoperazone-Sulbactam / Amoxicillin-Clavulanate IV

SEVERE (ICU)
   ↓
Pip-Tazo / Cefepime / Meropenem ± Vancomycin/Linezolid

MDR/XDR (Last Resort)
   ↓
Colistin / Ceftazidime-Avibactam / Ceftolozane-Tazo / Tigecycline

---

De-escalation principle: Start broad empirically, then narrow to the most targeted antibiotic once culture and sensitivity results are available. This reduces resistance, side effects, and cost.